Protein and gene expression of estrogen receptor alpha and nuclear morphology of two breast cancer cell lines after different fixation methods

被引:8
|
作者
Nykanen, Marjukka [1 ]
Kuopio, Teijo [1 ]
机构
[1] Cent Finland Cent Hosp, Dept Pathol, Jyvaskyla 40620, Finland
关键词
Fixation; Immunohistochemistry; Q-PCR; Estrogen receptor; Breast cancer; PARAFFIN-EMBEDDED TISSUES; IMMUNOHISTOCHEMISTRY; ISSUES; TIME;
D O I
10.1016/j.yexmp.2009.12.003
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We assessed morphology and ER alpha protein and gene expression of two breast cancer cell lines after three different fixatives: neutral-buffered 10% formaldehyde, LN-FIX and FineFIX and varying fixation times. We found that the cell morphology was best preserved in cells fixed with LN-FIX. Two commercial fixatives used in this study shrank cells less than formalin. In immunohistochemical assay samples were stained with two different ERa antibodies, clone 1DS and clone SP1. All tested fixatives were suitable for immunohistochemistry. Staining was more intensive and the number of stained cells was larger with the clone 105 than with the clone SPI. Our gene expression analysis showed that formalin and LN-FIX preserve the ER alpha better than FineFIX, which is advertised to be optimal for molecular analysis. Our study suggests that tissues fixed with formalin are suitable also for molecular biology assays. This makes possible to research formalin-fixed paraffin-embedded archival tissues also with molecular techniques. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 50 条
  • [1] Expression of an estrogen receptor alpha variant protein in cell lines and tumors
    Fasco, MJ
    Keyomarsi, K
    Arcaro, KF
    Gierthy, JF
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 162 (1-2) : 167 - 180
  • [2] Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines
    Lattrich, Claus
    Stegerer, Anette
    Haering, Julia
    Schueler, Susanne
    Ortmann, Olaf
    Treeck, Oliver
    STEROIDS, 2013, 78 (02) : 195 - 202
  • [3] Role of estrogen receptor in breast cancer cell gene expression
    Zheng, Yabing
    Shao, Xiying
    Huang, Yuan
    Shi, Lei
    Chen, Bo
    Wang, Xiaojia
    Yang, Hongjian
    Chen, Zhanhong
    Zhang, Xiping
    MOLECULAR MEDICINE REPORTS, 2016, 13 (05) : 4046 - 4050
  • [4] Reassessment of Estrogen Receptor Expression in Human Breast Cancer Cell Lines
    Ford, Christopher H. J.
    Al-Bader, Mate
    Al-Ayadhi, Bushra
    Francis, Issam
    ANTICANCER RESEARCH, 2011, 31 (02) : 521 - 527
  • [5] Correlation between erythropoietin receptor(s) and estrogen and progesterone receptor expression in different breast cancer cell lines
    Trost, Nina
    Hevir, Neli
    Rizner, Tea Lanisnik
    Debeljak, Natasa
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 31 (03) : 717 - 725
  • [6] Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines
    Tan, Huining
    Zhong, Yili
    Pan, Zhongzong
    BMC CANCER, 2009, 9
  • [7] Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines
    Huining Tan
    Yili Zhong
    Zhongzong Pan
    BMC Cancer, 9
  • [8] Expression of progesterone receptor isoforms A and B is differentially regulated by estrogen in different breast cancer cell lines
    Vienonen, A
    Syvälä, H
    Miettinen, S
    Tuohimaa, P
    Ylikomi, T
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 80 (03): : 307 - 313
  • [9] Induction of estrogen receptor α-36 expression by bone morphogenetic protein 2 in breast cancer cell lines
    Wang, Dingding
    Huang, Peide
    Zhu, Baowei
    Sun, Li
    Huang, Qing
    Wang, Ju
    MOLECULAR MEDICINE REPORTS, 2012, 6 (03) : 591 - 596
  • [10] Different cell activities in breast cancer based on different estrogen receptor-alpha(+)/estrogen receptor-alpha(-) ratios.
    Li, Yanchu
    Zhang Hengli
    Gou Qiheng
    Zhang Jiahui
    Ping Li
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)